Protein adsorption influences the interactions that occur at the tissue-implant interface. Protein adsorption can lead to blood clots, the foreign-body response and ultimately the degradation of the device. In order to counter-act the effects of protein adsorption, implants are often coated with a polymer coating to decrease protein adsorption.
Polyethylene glycol (PEG) coatings have been shown to minimize protein adsorption in the body. The PEG coating consists of hydrophilic molecules that are repulsive to protein adsorption. Proteins consist of hydrophobic molecules and charge sites that want to bind to other hydrophobic molecules and oppositely charged sites. By applying a thin  monolayer coating of PEG, protein adsorption is prevented at the device site. Furthermore, the device's resistance to protein adsorption, fibroblast adhesion and bacteria  adhesion are increased.